Cargando…
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study
BACKGROUND: In the United States, people with relapsing-remitting multiple sclerosis (RRMS) can face difficulty accessing disease-modifying therapies (DMTs) because of insurance, pharmacy, or provider policies. These barriers have been associated with poor adherence and negative health outcomes. OBJ...
Autores principales: | Simacek, Kristina F, Ko, John J, Moreton, Debbie, Varga, Stefan, Johnson, Kristen, Katic, Bozena J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234348/ https://www.ncbi.nlm.nih.gov/pubmed/30377144 http://dx.doi.org/10.2196/11168 |
Ejemplares similares
-
Barriers to access and utilisation of sexual and reproductive health services among adolescents in Ethiopia: a sequential mixed-methods study
por: Wakjira, Daniel Bekele, et al.
Publicado: (2022) -
Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
por: Zhang, Yinan, et al.
Publicado: (2021) -
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
por: Filippi, Massimo, et al.
Publicado: (2021) -
Health economic outcomes of switching to alemtuzumab from other disease-modifying therapies in people with multiple sclerosis in the USA
por: Araujo, Lita, et al.
Publicado: (2022) -
Public Funding and Open Access to Research: A Review of Canadian Multiple Sclerosis Research
por: Bakker, Caitlin, et al.
Publicado: (2017)